Xcout Intel
Meta Pharmaceuticals
META Pharmaceuticals Inc. is a pioneering biotechnology company focusing on immuno-metabolism and gastrointestinal therapeutics within immunology, operating research efforts connected to JLABS in Shanghai.
Subscribe to see Meta Pharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Meta Pharmaceuticals at a glance
Meta Pharmaceuticals is a drug discovery company. It has raised at least $15M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round closed in February 2025. Xcout tracks 8 named people at Meta Pharmaceuticals, including Guoxing Wei (天图资本合伙人).
Meta Pharmaceuticals leadership
- Guoxing Wei天图资本合伙人
- Shuhao Wen晶泰科技创始人/董事长
- Tianxiang Tang执行合伙人/融资负责人
- Yide Jiang晶泰科技首席策略官 & IMO创投合伙人
- Anjin Xianyu联合创始人/首席技术官
- Ke Xu创始人/首席执行官
2 more named people on record for Meta Pharmaceuticals, with roles, board committees and tenure — see the full roster →
Meta Pharmaceuticals funding rounds
At least $15M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | Undisclosed | 4 named | |
| — | $15M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Meta Pharmaceuticals competitors
A few of Meta Pharmaceuticals's closest competitors — see the full list of competitors and alternatives →
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
COUR Pharmaceuticals is a clinical-stage biotechnology company headquartered in Evanston, Illinois, founded in 2015. The firm focuses on reprogramming the immune system to develop novel treatments for autoimmune diseases.
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Vivacta Biotechnology is a biopharmaceutical company headquartered in Shanghai, China, specializing in innovative biotechnology research. The company is focused on developing in vivo CAR-T therapies utilizing a targeted delivery system.
Metsera, Inc. is a clinical-stage biopharmaceutical company traded on the NASDAQ under the symbol MTSR, with its headquarters located in New York, New York, focusing on next-generation obesity and metabolic portfolios.
Get Meta Pharmaceuticals's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Meta Pharmaceuticals in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access